BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3490399)

  • 1. Purification of the enhancing factor from mouse intestines.
    Mulherkar R; Saraf A; Wagle A; Deo MG
    FEBS Lett; 1986 Oct; 207(1):142-4. PubMed ID: 3490399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing factor protein from mouse small intestines belongs to the phospholipase A2 family.
    Mulherkar R; Rao R; Rao L; Patki V; Chauhan VS; Deo MG
    FEBS Lett; 1993 Feb; 317(3):263-6. PubMed ID: 8425615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of a low molecular weight transforming growth factor from the urine of melanoma patients.
    Kim MK; Warren TC; Kimball ES
    J Biol Chem; 1985 Aug; 260(16):9237-43. PubMed ID: 2991238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing activity and phospholipase A2 activity: two independent activities present in the enhancing factor molecule.
    Kadam S; Mulherkar R
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):237-43. PubMed ID: 10229680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ontogeny of enhancing factor in mouse intestines and skin.
    Desai SJ; Mulherkar R; Wagle AS; Deo MG
    Histochemistry; 1991; 96(4):371-4. PubMed ID: 1723979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further studies on the enhancing factor and its possible mechanism of action.
    Mulherkar R; Deo MG
    J Cell Physiol; 1986 Apr; 127(1):183-8. PubMed ID: 3007538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human transforming growth factor. Production by a melanoma cell line, purification, and initial characterization.
    Marquardt H; Todaro GJ
    J Biol Chem; 1982 May; 257(9):5220-5. PubMed ID: 6279663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and initial characterization of a type beta transforming growth factor from human placenta.
    Frolik CA; Dart LL; Meyers CA; Smith DM; Sporn MB
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3676-80. PubMed ID: 6602340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of a novel transforming growth factor.
    Halper J; Moses HL
    Cancer Res; 1987 Sep; 47(17):4552-9. PubMed ID: 2887280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of two biologically active peptides, erythrotropin I and erythrotropin II from fetal calf intestine.
    Congote LF
    Biochem Biophys Res Commun; 1983 Sep; 115(2):477-83. PubMed ID: 6688730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of EGF-dependent transforming growth factor (TGF beta-like) activity from culture medium conditioned by fetal rat calvariae.
    Centrella M; Canalis E
    J Bone Miner Res; 1987 Feb; 2(1):29-36. PubMed ID: 3502665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing factor, a Paneth cell specific protein from mouse small intestines: predicted amino acid sequence from RT-PCR amplified cDNA and its expression.
    Mulherkar R; Rao RS; Wagle AS; Patki V; Deo MG
    Biochem Biophys Res Commun; 1993 Sep; 195(3):1254-63. PubMed ID: 8267767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of enhancing factor gene and its localization in mouse tissues.
    Mulherkar R; Desai SJ; Rao RS; Wagle AS; Deo MG
    Histochemistry; 1991; 96(4):367-70. PubMed ID: 1787109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence analysis of full length cDNA for enhancing factor/phospholipase A2.
    Kadam S; Deshpande C; Coulier F; Mulherkar R
    Indian J Exp Biol; 1998 Jun; 36(6):553-8. PubMed ID: 9731467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factors from a human tumor cell: characterization of transforming growth factor beta and identification of high molecular weight transforming growth factor alpha.
    Dart LL; Smith DM; Meyers CA; Sporn MB; Frolik CA
    Biochemistry; 1985 Oct; 24(21):5925-31. PubMed ID: 3002426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of a high molecular weight form of epidermal growth factor from urine of breast cancer patients.
    Eckert K; Granetzny A; Fischer J; Grosse R
    Biomed Biochim Acta; 1989; 48(1):111-20. PubMed ID: 2789043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rat pancreatic phospholipase A2: purification, characterization, and N-terminal amino acid sequence.
    Ono T; Tojo H; Inoue K; Kagamiyama H; Yamano T; Okamoto M
    J Biochem; 1984 Sep; 96(3):785-92. PubMed ID: 6501264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and properties of a type beta transforming growth factor from bovine kidney.
    Roberts AB; Anzano MA; Meyers CA; Wideman J; Blacher R; Pan YC; Stein S; Lehrman SR; Smith JM; Lamb LC
    Biochemistry; 1983 Dec; 22(25):5692-8. PubMed ID: 6607069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and partial characterization of a bovine epidermal growth factor-like polypeptide.
    Byatt JC; Larson BR; Baganoff MP; McGrath MF; Collier RJ
    Biochem Int; 1990; 20(6):1179-87. PubMed ID: 2369415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of extracellular phospholipase A2 from peritoneal cavity of caseinate-treated rat.
    Chang HW; Kudo I; Tomita M; Inoue K
    J Biochem; 1987 Jul; 102(1):147-54. PubMed ID: 3667563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.